Evoke Announces FDA Submission of New Drug Application for Gimoti

SOLANA BEACH, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced the submission of its 505(b)(2) New Drug...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news